d-alpha tocopherol has been researched along with spironolactone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mihas, AA; Saccomani, G; Spenney, JG | 1 |
| Johnson, SR | 1 |
| Deretzi, G; Katsiki, E; Kountouras, J; Patsiaoura, K; Polyzos, SA; Rakitzi, P; Slavakis, A; Tsarouchas, G; Zafeiriadou, E; Zavos, C | 1 |
| Alzoubi, KH; Bonyan, R; Mayyas, F | 1 |
| Katsinelos, P; Kountouras, J; Mantzoros, CS; Polymerou, V; Polyzos, SA | 1 |
| Anastasilakis, AD; Doulberis, M; Hawa, G; Katsinelos, P; Kountouras, J; Makras, P; Missbichler, A; Polyzos, SA; Sonnleitner, L; Terpos, E | 1 |
2 review(s) available for d-alpha tocopherol and spironolactone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Premenstrual syndrome therapy.
Topics: Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Contraceptives, Oral, Combined; Danazol; Evidence-Based Medicine; Exercise Therapy; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Gonadotropin-Releasing Hormone; Humans; Linoleic Acids; Oenothera biennis; Ovariectomy; Plant Oils; Premenstrual Syndrome; Progesterone; Progestins; Pyridoxine; Selective Serotonin Reuptake Inhibitors; Spironolactone; Vitamin E | 1998 |
3 trial(s) available for d-alpha tocopherol and spironolactone
| Article | Year |
|---|---|
Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease.
Topics: Animals; Fatty Liver; Female; Humans; Insulin Resistance; Male; Mice; Middle Aged; Mineralocorticoid Receptor Antagonists; Non-alcoholic Fatty Liver Disease; Spironolactone; Vitamin E | 2011 |
Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.
Topics: Adipokines; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Biopsy; Combined Modality Therapy; Dietary Supplements; Female; Humans; Hyperinsulinism; Insulin Resistance; Intention to Treat Analysis; Liver; Liver Cirrhosis; Male; Mineralocorticoid Receptor Antagonists; Non-alcoholic Fatty Liver Disease; Severity of Illness Index; Spironolactone; Ultrasonography; Vitamin E | 2017 |
Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.
Topics: Carrier Proteins; Case-Control Studies; Drug Therapy, Combination; Humans; Mineralocorticoid Receptor Antagonists; Non-alcoholic Fatty Liver Disease; Spironolactone; Vitamin E | 2018 |
3 other study(ies) available for d-alpha tocopherol and spironolactone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
LSA--a new liver-specific antigen in the rat. II: Immunological and biological properties.
Topics: Animals; Bile Acids and Salts; Carbon Tetrachloride; Chromatography; Counterimmunoelectrophoresis; Embryonic and Fetal Development; Female; Galactosamine; Guinea Pigs; Immunodiffusion; Iodine Radioisotopes; Isoantibodies; Isoantigens; Liver; Mice; Mice, Inbred BALB C; Phylogeny; Propylthiouracil; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Spironolactone; Vitamin E | 1994 |
The role of spironolactone on myocardial oxidative stress in rat model of streptozotocin-induced diabetes.
Topics: Aldosterone; Animals; Blood Pressure; Catalase; Cytochrome P-450 CYP11B2; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Lipid Peroxidation; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Nitrites; Oxidation-Reduction; Oxidative Stress; Rats, Sprague-Dawley; Spironolactone; Streptozocin; Superoxide Dismutase; Time Factors; Tyrosine; Vitamin E | 2017 |